|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities: | |||||
| Net loss | |||||
| Loss from discontinued operations | |||||
| Loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Stock and share-based compensation | |||||
| Change in fair value of derivative warrant liability | |||||
| Impairment of goodwill | |||||
| Loss (gain) on disposition and involuntary conversion of property and equipment | |||||
| Gain on extinguishment of PPP loan | |||||
| Provision for bad debts | |||||
| Accretion of interest | |||||
| Impairment of Golden Ridge assets | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable and accrued expenses | |||||
| Commodities payable | |||||
| Other | |||||
| Net cash used in operating activities of continuing operations | |||||
| Net cash used in operating activities of discontinued operations | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Proceeds from insurance on involuntary conversion | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash used in investing activities of continuing operations | |||||
| Net cash provided by (used in) investing activities of discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from Long-Term Lines of Credit | |||||
| Factoring Agreement | |||||
| Line of Credit With Bank | |||||
| Total proceeds from Long-Term Lines of Credit | |||||
| Payments on factoring agreement | |||||
| Factoring Agreement | |||||
| Total payments on factoring agreement | |||||
| Payments on bank line of credit | |||||
| Line of Credit With Bank | |||||
| Total payments on bank line of credit | |||||
| Advances on insurance premium finance agreements | |||||
| Payments on insurance premium finance agreements | |||||
| Advances on long-term debt, net of issuance costs | |||||
| Advances on long-term debt and finance lease agreements | |||||
| Payments of long-term debt and finance lease liabilities | |||||
| Proceeds from common stock warrant exercises | |||||
| Net cash provided by (used in) financing activities of continuing operations | |||||
| Net cash used in financing activities of discontinued operations | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
Loading...